Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-23-013779
Filing Date
2023-04-28
Accepted
2023-04-28 16:18:59
Documents
1
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3a.html 3/A  
1 PRIMARY DOCUMENT form3a.xml 3/A 3334
  Complete submission text file 0001127602-23-013779.txt   4862
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOGEN INC. 225 BINNEY ST. CAMBRIDGE MA 02142
Business Address
Guindo Chirfi (Reporting) CIK: 0001722753 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-06571 | Film No.: 23866562